From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Cardiology>
  4. Summary and Comment

Adenosine-Induced Atrial Arrhythmia.

Adenosine is frequently used for the treatment of paroxysmal supraventricular tachycardia (PSVT), but there has been concern that adenosine in this setting can trigger atrial fibrillation or flutter in some patients. To test this hypothesis, University of Michigan investigators prospectively administered 12 mg of intravenous adenosine to 200 consecutive patients undergoing electrophysiologic evaluation of PSVT.

The mechanism responsible for PSVT was atrioventricular nodal reentrant tachycardia in 124 patients, atrioventricular reciprocating tachycardia in 68, and atrial tachycardia in 8. Adenosine induced atrial fibrillation or flutter in 12 percent of patients. In all cases, atrial fibrillation developed after an atrial premature beat causing a long-short sequence typically associated with reentrant arrhythmias. Of note, there was no association between the underlying mechanism of the PSVT and the risk for adenosine-induced atrial fibrillation or flutter.

Comment: This prospective study clearly demonstrates an association between administration of 12 mg of IV adenosine and post-cardioversion atrial arrhythmias, at least in the electrophysiology laboratory. The authors point out that these acute rhythms can be quite dangerous in the presence of a concealed, antegrade conducting bypass tract. Thus, in patients with PSVT where a bypass tract mechanism may be responsible, adenosine should be used only where emergency resuscitation is feasible.

— MS Lauer

Published in Journal Watch Cardiology November 10, 1997

Citation(s):

Strickberger SA et al. Adenosine-induced atrial arrhythmia: A prospective analysis. Ann Intern Med 1997 Sep 15 127 417-422.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 1997. Massachusetts Medical Society. All rights reserved.